MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using precision delivery to power the next wave of mRNA and gene correction therapeutics, today ...
MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
– Abstract selected for oral presentation at 2026 American Thoracic Society International Conference – ReCode Therapeutics, a clinical-stage genetic medicines company using lipid nanoparticle delivery ...
Dr. Shehnaaz Suliman is the new chief executive officer and member of the board of ReCode Therapeutics. Biopharmaceutical company ReCode Therapeutics announced today the appointment of Dr. Shehnaaz ...
Collaboration combines Intellia’s leading CRISPR-based platform, including its DNA writing technology, with ReCode’s proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) to extend the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results